ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #5,258Gold OA

Vaccines

Abbreviation (ISO):VACCINES-BASEL
•
Identifier (ISSN):2076-393X(Print)
•
Publisher:MDPI (Basel, Switzerland)
Clarivate IF (2026)
3.5↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Vaccines

WoS Q2
03710020184.7620194.0920204.4220214.9620227.820235.220243.420253.52026
Annual Impact Factor Metric
Current (2026):3.5
Scopus SJR & RankScopus Q1
0.955
#5,258

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
111

111 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate17.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
1,440articles/year
100% Gold OA•84.56% Original Research

Aims & Scope

Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in open access form in as much detail as possible. The full experimental details must be provided so that the results can be reproduced.

Topics Covered (Recognized by AI)
Medicine98.3%Biology97.2%Immunology92.2%Virology82.8%Pathology78.1%Genetics75.3%Internal medicine71.5%Vaccination60.7%Immune system51.7%Antibody48.5%Chemistry43.8%Biochemistry41.8%Antigen41.4%Disease38.2%Virus36.5%Infectious disease (medical specialty)32%Coronavirus disease 2019 (COVID-19)31.6%Gene27.3%Sociology26.4%Environmental health24.1%Demography24%Mathematics22.1%Family medicine20.4%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q2
Rank89/183
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank82/191
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q2
Rank86/183
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank78/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.5
Articles / Year776
Total Citations300
2025
IF3.4
Articles / Year1,278
Total Citations4,539
2024
IF5.2
Articles / Year1,436
Total Citations10,483
2023
IF7.8
Articles / Year1,816
Total Citations22,073
2022
IF4.961
Articles / Year2,216
Total Citations38,363

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,258Scopus Q1SCImago Profile
Scopus Coverage:2013-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
0.955

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.61

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,426 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations19,379
3-Year Documents5,469
Citable Documents5,360

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)15

Citations in government and international policy documents

Female Author Rate50.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q1
Drug DiscoveryQ2
ImmunologyQ2
Infectious DiseasesQ2
PharmacologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 17.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
In warning list
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Vaccines (abbr: VACCINES-BASEL, ISSN: 2076-393X) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by MDPI (Basel, Switzerland) in Switzerland since 2013. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.955 (Q1), an H-index of 111.

The journal enforces rigorous peer evaluation with an annual output of approximately 1,440 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,426 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
MDPI (Basel, Switzerland)
Publication Language
English
Frequency
Periodic
Founding Year
2013
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 9a148b41-3abc-47b8-ac3b-55036562e7a8
Database Updated: 2026-10-01